A First-in-Human Study Investigating BG-85738 Alone or in Combination With Other Antitumor Agents in Patients With Advanced or Metastatic Solid Tumors With Rat Sarcoma Virus (RAS) Mutations

NCT07746141 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

RAS Mutation
Advanced Solid Tumor
Metastatic Solid Tumor

Interventions

DRUG: BG-85738
DRUG: Tislelizumab
DRUG: Cetuximab

Sponsor

BeOne Medicines